Volume 25, Number 11—November 2019
Nasopharyngeal Pneumococcal Density during Asymptomatic Respiratory Virus Infection and Risk for Subsequent Acute Respiratory Illness
|Median age at enrollment (IQR), mo||7.7 (1.0–18.8)|
|No. samples per child (IQR)||2 (1–2)|
|No. persons per household (IQR), n = 476
|No. children age <5 y in household, n = 476|
|Shares a bed, n = 473||461 (97)|
|Received >1 PCV7 dose, n = 468||262 (56)|
*Values are no. (%) children unless indicated otherwise. IQR, interquartile range; PCV7, 7-valent pneumococcal conjugate vaccine.
Page created: October 15, 2019
Page updated: October 15, 2019
Page reviewed: October 15, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.